Here are five things to know:
1. Michael A. McManus, Jr., will step down from his positions as director and chairman of the board of directors as well as president and CEO.
2. Stavros G. Vizirgianakis, a member of Misonix’s board of directors, will fill Mr. McManus’ place as the interim CEO.
3. Misonix is currently pursuing options with Mr. Vizirgianakis to fill the full-time position of CEO.
4. Mr. Vizirgianakis has served on the board since May 2013 and has a 5.7 percent ownership state in the company.
5. Misonix develops ultrasonic products for spine surgery, neurosurgery, wound debridement, skull base surgery and laparoscopic surgery, among other applications.
More articles on devices:
J&J, SI-BONE, Medtronic & more: 10 key notes
Global wearable health sensors market to hit $48.6M by 2018: 4 observations
Global orthopedic implants market to hit $6.2B by 2024 — 7 points
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
